CSIMarket Company Name, Ticker, Competitors, else..
 
Biorestorative Therapies Inc   (NASDAQ: BRTX)
Other Ticker:  
 
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 
Price: $1.7300 $-0.05 -2.809%
Day's High: $1.75 Week Perf: -0.29 %
Day's Low: $ 1.70 30 Day Perf: 3.59 %
Volume (M): 3 52 Wk High: $ 2.55
Volume (M$): $ 5 52 Wk Avg: $1.66
Open: $1.70 52 Wk Low: $1.03



 Market Capitalization (Millions $) 13
 Shares Outstanding (Millions) 8
 Employees 7
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -9
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Biorestorative Therapies Inc
Biorestorative Therapies Inc is a biotechnology company that focuses on developing and commercializing innovative therapies for various diseases and injuries. The company specializes in regenerative medicine, which involves using the body's own cells to repair damaged tissues and organs.

Biorestorative Therapies Inc's primary areas of focus include human cell and tissue products, bioartificial organs, and medical devices. Their therapies aim to address a wide range of conditions, such as cardiac and vascular diseases, metabolic disorders, neurodegenerative diseases, and orthopedic injuries.

The company's research and development efforts are dedicated to advancing stem cell-based technologies, including stem cell collection, isolation, expansion, and differentiation. Biorestorative Therapies Inc also seeks to enhance the delivery methods for stem cell therapies to improve their effectiveness and patient outcomes.

Overall, Biorestorative Therapies Inc aims to revolutionize the field of regenerative medicine by developing novel therapies that have the potential to change the standard of care for a variety of conditions.


   Company Address: 40 Marcus Drive Melville 11747 NY
   Company Phone Number: 760-8100   Stock Exchange / Ticker: NASDAQ BRTX


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ALT        7.09% 
AMGN   -3.04%    
PFE        1.07% 
REGN   -3.26%    
SNY   -1.19%    
• View Complete Report
   



Biorestorative Therapies Inc

BRTX's Regenerative Medicine Faces Setbacks but Shows Promising Improvement in Losses

Biorestorative Therapies Inc, a leading company in the field of regenerative medicine, has faced some challenges in its financial performance in recent years. The company's lower turnover has directly affected its revenue, leading to a greater shortfall in the financial span closing June 30, 2023. However, despite these setbacks, the company has managed to decrease its loss per share, a positive sign for its shareholders.
In the said financial period, Biorestorative Therapies Inc recorded a loss of $0.77 per share, a significant improvement compared to the previous year's figure of $1.53 per share. This demonstrates the company's efforts to mitigate its losses and improve its financial position. However, it should be noted that the revenue has fallen by 9.283% to $0.06 million year-on-year, indicating a decline in the company's overall performance.
Biorestorative Therapies Inc

Biorestorative Therapies Inc Reports Significant Increase in Losses, But Revenue Holds Steady

Biorestorative Therapies Inc (BRTX) recently announced its financial results for its most recent fiscal period. The company reported a loss per share of $-1.53 compared to a loss per share of $-0.01 in the same period last year. This loss per share also increased from the prior reporting period's loss per share of $-1.28.
Despite the increase in losses, BRTX's revenue remained relatively stable, coming in at $0.03 million for both the most recent fiscal period and the same period a year ago. However, the company did see a sequential revenue increase of 7.931% from the previous reporting period.






Biorestorative Therapies Inc's Segments
Product    98.76 % of total Revenue
Royalty    1.24 % of total Revenue





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com